216 filings
Page 2 of 11
8-K
mjlxsp8ac vdt1vbvu
17 May 22
Nephros Receives FDA 510(k) Clearance for HDF Assist Module
4:46pm
8-K
rmu 2hknumlux0
4 May 22
Active Customer Sites Climb 17% to New Record
4:09pm
8-K
2wjxwjtxc
23 Feb 22
Nephros Announces Fourth Quarter and Fiscal Year 2021 Financial Results
4:34pm
8-K
548edtyh hf
13 Jan 22
Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2021 and Revenue Guidance for 2022
7:30am
8-K
lan og2n0n
3 Dec 21
Changes in Registrant's Certifying Accountant
4:38pm
8-K
xphbm dl75gb19h
8 Oct 21
Nephros Announces Preliminary Results for Third Quarter of 2021
7:45am
8-K
ui6heh vbw28sh
2 Sep 21
Nephros Appoints Wes Lobo to Chief Commercial Officer
8:53am
8-K
q26s2d9xbz1i580
5 Aug 21
Results of Operations and Financial Condition
4:27pm
8-K
u2dfgb rz62zwi41
12 Jul 21
Strategic Acquisition Accelerates Pathogen Detection Product Development
10:30am
8-K
l3go99
8 Jul 21
Nephros Announces Preliminary Results for Second Quarter of 2021
9:22am
8-K
37klea 2b4tlg2
20 May 21
Departure of Directors or Certain Officers
5:20pm
8-K
tvgn28 jdar6o9
6 May 21
Net Revenue of $2.7 Million; Highest First Quarter in Company History
4:15pm
8-K
bjue3f9g9fgencl
5 Apr 21
Nephros Announces Preliminary Results for First Quarter of 2021
7:47am
8-K
mvki7 d02z6y1h81
31 Mar 21
Departure of Directors or Certain Officers
4:15pm
8-K
hj03 vvfsi90a27wo44
29 Mar 21
Other Events
5:15pm
8-K
4d4m tggwa
1 Mar 21
Nephros Reports 2020 Fourth Quarter and Full Year Financial Results
4:20pm
8-K
9xo3x hjqvwfn
3 Feb 21
Departure of Directors or Certain Officers
5:10pm
8-K
ln4e2r fvvb
12 Jan 21
Nephros Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2020
10:51am
8-K
dwx0wy
5 Nov 20
Nephros Appoints Dan D’Agostino as CFO
4:18pm
8-K
8kgr4 xoho5nucw
29 Oct 20
Departure of Directors or Certain Officers
4:15pm